Cargando…
Survivin: a unique target for tumor therapy
Survivin is the smallest member of the Inhibitor of apoptosis (IAP) family of proteins, involved in inhibition of apoptosis and regulation of cell cycle. These functional attributes make Survivin a unique protein exhibiting divergent functions i.e. regulating cell proliferation and cell death. Expre...
Autores principales: | Garg, Himani, Suri, Prerna, Gupta, Jagdish C., Talwar, G. P., Dubey, Shweta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917988/ https://www.ncbi.nlm.nih.gov/pubmed/27340370 http://dx.doi.org/10.1186/s12935-016-0326-1 |
Ejemplares similares
-
Combination immunotherapy with Survivin and luteinizing hormone-releasing hormone fusion protein in murine breast cancer model
por: Garg, Himani, et al.
Publicado: (2018) -
Survivin as a Preferential Target for Cancer Therapy
por: Mobahat, Mahsa, et al.
Publicado: (2014) -
A unique case of bilateral nanophthalmos and pigmentary retinal abnormality with unilateral angle closure glaucoma and optic disc pit
por: Garg, Prerna, et al.
Publicado: (2023) -
Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
por: Kelly, Ronan J, et al.
Publicado: (2011) -
Survivin – biology and potential as a therapeutic target in oncology
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2013)